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A b s t r a c t
This study compared acid-base and biochemical changes and quality of recovery in male cats with experimentally induced 
urethral obstruction and anesthetized with either propofol or a combination of ketamine and diazepam for urethral 
catheterization. Ten male cats with urethral obstruction were enrolled for urethral catheterization and anesthetized with either 
ketamine-diazepam (KD) or propofol (P). Lactated Ringer’s solution was administered by intravenous (IV) beginning 15 min 
before and continuing for 48 h after relief of urethral obstruction. Quality of recovery and time to standing were evaluated. The 
urethral catheter was maintained to measure urinary output. Hematocrit (Hct), total plasma protein (TPP), albumin, total protein 
(TP), blood urea nitrogen (BUN), creatinine, pH, bicarbonate (HCO3
2), chloride, base excess, anion gap, sodium, potassium, 
and partial pressure of carbon dioxide in mixed venous blood (pvCO2) were measured before urethral obstruction, at start of 
fluid therapy (0 h), and at subsequent intervals. The quality of recovery and time to standing were respectively 4 and 75 min in 
the KD group and 5 and 16 min in the P group. The blood urea nitrogen values were increased at 0, 2, and 8 h in both groups. 
Serum creatinine increased at 0 and 2 h in cats administered KD and at 0, 2, and 8 h in cats receiving P, although the values were 
above the reference range in both groups until 8 h. Acidosis occurred for up to 2 h in both groups. Acid-base and biochemical 
stabilization were similar in cats anesthetized with propofol or with ketamine-diazepam. Cats that received propofol recovered 
much faster, but the ketamine-diazepam combination was shown to be more advantageous when treating uncooperative cats 
as it can be administered by intramuscular (IM) injection.
Résumé
Cette étude visait à comparer les changements biochimiques et acide-base ainsi que la qualité de la convalescence chez des chats mâles avec une 
obstruction urétrale induite expérimentalement et anesthésiés avec soit du propofol ou une combinaison de kétamine et diazépam pour une 
cathétérisation urétrale. Dix chats mâles avec une obstruction urétrale ont été recrutés pour cathétérisation urétrale et anesthésiés avec soit 
une combinaison kétamine-diazépam (KD) ou du propofol (P). Une solution de lactate de Ringer a été administrée par voie intraveineuse (IV) 
débutant 15 min avant et continuant 48 h après l’élimination de l’obstruction urétrale. La qualité de la convalescence et le délai avant de se 
tenir debout ont été évalués. Le cathéter urinaire était laissé en place pour mesurer l’excrétion urinaire. Les valeurs des paramètres suivants 
ont été mesurées avant l’obstruction urétrale, au début de la fluidothérapie (0 h) et à des intervalles subséquents : hématocrite (Hct), protéines 
plasmatiques totales (TPP), albumine, protéines totales (TP), azotémie (BUN), créatinine, pH, bicarbonate (HCO3
2), chlorure, excès de base, 
trou anionique, sodium, potassium, pression partielle de dioxide de carbone dans le sang veineux (pvCO2). La qualité de la convalescence et 
le temps avant de se tenir debout étaient respectivement de 4 et 75 minutes dans le groupe KD et de 5 et 16 minutes dans le groupe P. Les 
valeurs de BUN étaient augmentées à 0, 2 et 8 h dans les deux groupes. La créatinine sérique augmenta à 0 et 2 h chez les chats recevant KD 
et à 0, 2 et 8 h chez les chats recevant P, bien que les valeurs étaient supérieures à l’écart de référence dans les deux groupes jusqu’à 8 h. Une 
acidose s’est produite pendant 2 h dans les deux groupes. L’équilibre acide-base et la stabilisation biochimique étaient similaires chez les chats 
anesthésiés avec du propofol ou avec KD. Les chats qui ont reçu du propofol ont récupéré beaucoup plus rapidement, mais la combinaison KD 
s’est avérée plus avantageuse pour traiter des chats non-coopératifs étant donné la possibilité d’administration par voie intra-musculaire.
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I n t r o d u c t i o n
Urethral obstruction is one of the most common emergencies 
involving the urinary tract in cats. If untreated, it can rapidly 
progress to severe acid-base disturbances (1). In addition to azo-
temia, metabolic acidosis, hyperkalemia, hyperphosphatemia, and 
hypocalcemia are also observed. Over a prolonged period, urethral 
obstruction results in fluid depletion, which culminates in hypovo-
lemia and hypoperfusion (2).
Glomerular filtration rate decreases 4 to 5 h after the onset of 
urethral obstruction due to the increase in intrarenal and intratu-
bular pressure (3). Since kidneys directly and indirectly excrete 
some anesthetic agents, these drugs must be selected carefully for 
patients with renal impairment. The renal patient becomes suscep-
tible to pharmacological overdose due to disturbances in plasma 
protein concentrations, drug ionization, pharmacokinetic effects, 
and excretion (4). Moreover, anesthetic agents can worsen cardio-
vascular depression in hyperkalemic cats, which makes it essential 
to reduce serum levels of potassium before anesthesia and relief of 
urethral obstruction (5).
In docile or severely depressed animals, physical restraint, pos-
sibly combined with topical anesthesia, is an alternative to anes-
thetic agents. The risks associated with anesthetics, however, must 
be compared with the possibility of iatrogenic urethral trauma in 
an uncooperative patient (6). Ketamine is widely used in cats as 
a chemical restraint and is especially advantageous in aggressive 
cats as it can be administered by intramuscular (IM) injection. It 
has been reported that low doses [1 to 2 mg/kg bodyweight (BW)] 
of ketamine given intravenously (IV) are adequate for the urethral 
release procedure, with the benefit of maintaining or increasing 
cardiac performance (6–9). The use of ketamine in cats with urethral 
obstruction is controversial, however, as most of the drug is excreted 
unchanged by the kidneys (6,7) and may accumulate in the body if 
the urethra of the patient is not relieved appropriately. It is therefore 
recommended that multiple doses of this anesthetic be avoided in 
cats in which the relief procedure is difficult or if this pathology 
has recurred. Such animals are predisposed to the occurrence of 
urethral stenosis, which might complicate the relief procedure (9) 
and consequently the excretion of the drug.
The available literature indicates that combining ketamine with 
diazepam relieves urethral obstruction in cats (6,8,9). This combina-
tion promotes urethral relaxation (9) and reduces muscle hypertonia 
and risks of convulsion (10) without changing the glomerular filtra-
tion rate (11). As the active metabolites of diazepam can contribute 
to prolonging depression in uremic animals (5), it is considered 
detrimental to use it alone in animals with urethral obstruction. 
Moreover, there were no pressor or cardiovascular stimulating effects 
detected with the ketamine-diazepam induction (12) and the effects 
of ketamine are not reversible and should not be used in animals 
with cardiac disease (9).
General anesthetics, such as propofol and inhalation anesthetics, 
should also be indicated if general anesthesia is necessary. These 
anesthetics should be administered cautiously in patients with 
post-renal azotemia, however, and lower-than-recommended doses 
should be used for patients with normal renal function (6). Propofol 
stands out for its smooth and rapid onset of action, short duration, 
and lack of systemic accumulation (13). Repeated administrations 
or continuous infusions of propofol are useful for maintaining 
short-term anesthesia in cats (14–16). It may become complicated in 
some cases, such as when the animal is aggressive or hypotensive, 
as venipuncture is required for its administration.
This study compared the acid-base and biochemical changes and 
the quality of recovery in male cats with experimentally induced 
urethral obstruction and anesthetized for urethral catheterization 
with either propofol or a combination of ketamine and diazepam.
M a t e r i a l s  a n d  m e t h o d s
This study was approved by the Institutional Animal Use and Care 
Committee (number 31/2008) of Federal University of Santa Maria. 
Ten adult, neutered male, mixed-breed cats, weighing from 3.5 to 
5 kg, were enrolled in a urethral obstruction model (parallel study) 
(17). All cats were proven to be healthy by clinical and laboratorial 
evaluation, which included complete blood count, alanine amino-
transferase, gama-glutamyltransferase, blood urea nitrogen (BUN), 
and creatinine.
After anesthesia with isoflurane in 100% oxygen by use of a facial 
mask and aseptic preparation of the preputial and peripreputial 
areas, urethral catheterization was performed with a 3.5 F poly-
propylene open-end catheter (Sovereign, 3.5 Tom Cat Catheter; 
Sherwood Medical, St. Louis, Missouri, USA) lubricated with 
lidocaine gel. The urethral catheter was occluded with the cap of 
a peripheral venous catheter and fixed in the peripreputial area 
using a simple interrupted suture with 3-0 monofilament nylon. For 
each cat, anesthesia to relieve urethral obstruction was performed 
when 3 out of 4 of the following clinicopathologic criteria were met: 
venous pH , 7.2; BUN concentration . 200 mg/dL; serum creatinine 
concentration . 397.8 mmol/L; and serum potassium concentration 
. 6.5 mEq/L.
The animals were randomly allocated into 2 groups: the KD group 
received a combination of ketamine (Ketalar 100 mg/mL; Parke-Davis, 
Rio de Janeiro, RJ, Brazil), 10 mg/kg BW and diazepam (Compaz 
5 mg/mL; Cristália Produtos Farmacêuticos, Itapira, SP, Brazil), 
0.5 mg/kg BW, IM; and the P group received propofol (Propovan 
10 mg/mL; Cristália Produtos Farmacêuticos), 5 mg/kg BW, IV, 
replicating a situation in which anesthesia was necessary for ure-
thral catheterization of the animal. If required, an additional dose of 
ketamine (5 mg/kg BW) and diazepam (0.25 mg/kg BW) would be 
administered by IM in the KD group and propofol (2.5 mg/kg BW, IV) 
in the P group.
For the relief procedure, venipuncture of the cephalic vein was car-
ried out with a 22-g catheter to administer lactated Ringer’s solution 
(Ringer com Lactato de Sódio; Aster Produtos Médicos, Sorocaba, 
SP, Brazil) by means of a volumetric infusion pump (Infusomat 
Compact; B. Braum, Niterói, RJ, Brazil) at a rate of 20 mL/kg BW 
per hour.
Anesthesia was induced by one of the anesthesia protocols 15 min 
after start of fluid therapy. After anesthesia was established, the 
urinary bladder was flushed with cold lactated Ringer’s solution 
until the effluent was clear (approximately 15 min). The urethral 
catheter was then connected to a low-vacuum drainage system to 
measure urinary output (UO). While under anesthesia, the jugular 
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was punctured with a 20-g catheter fixed appropriately, which was 
used to collect venous blood (3 mL) for laboratory tests. A thermal 
mattress was used to maintain body temperature at 37.8°C to 39.5°C. 
Fluid therapy was carried out for 48 h post-relief. The infusion rates 
were gradually reduced, administering 20 mL/kg BW per hour in 
the first 6 h, 15 mL/kg BW per hour until 12 h, 10 mL/kg BW per 
hour until 24 h, and 5 mL/kg BW per hour until 48 h of evaluation 
in accordance with a parallel study (17).
The quality of recovery and time to standing for each cat were 
evaluated by the same observer. The overall quality of the recovery 
was scored on the following subjective 5-point scale: 1 = poor — 
many attempts to stand, falls over repeatedly, marked ataxia; 2 = 
better — multiple attempts to stand, falls over occasionally, and 
significant ataxia; 3 = good — lies quietly, several attempts to stand, 
some ataxia; 4 = very good — lies quietly, few attempts to stand, 
mild ataxia; 5 = excellent — rolls into sternal recumbency, gets up 
without falling, minimal ataxia (16).
Venous blood gas and serum electrolyte were analyzed at base-
line and at 0, 2, 8, 12, 24, and 48 h after starting the fluid therapy. 
Hematocrit (Hct), total plasma protein (TPP), albumin, total protein 
(TP), blood urea nitrogen (BUN), and creatinine were measured at 
the same time points and also at 72 h and 7 d after starting the fluid 
therapy. Urine from the low-vacuum drainage system was mea-
sured at 2, 4, 8, 12, 24, and 48 h. After relief of urethral obstruction, 
a syringe was attached to the urethral catheter to collect urine for 
performing urinalysis.
Cats received meloxicam (Maxicam 0.2%; Ouro Fino Saúde 
Animal, Cravinhos, SP, Brazil), 0.1 mg/kg BW, IM, q24h starting on 
the day the occluded urethral catheter was placed and continuing 
up to 3 d after relief of urethral obstruction. At the end of the study, 
all cats were donated to households.
All analyses were performed with standard software (GraphPad 
Prism; GraphPad Software, San Diego, California, USA). A repeated-
measures analysis of variance (ANOVA) was used, followed by 
Dunnett’s test to compare each variable except urinary output (UO) 
at the various time points with the baseline mean value within 
a group. Urinary output was compared among time points by 
repeated-measures ANOVA followed by the Tukey test. Values for 
each variable at each time point were compared between groups by 
use of the unpaired t-test. The quality of recovery was compared 
by the Mann-Whitney test. A value of P , 0.05 was considered sig-
nificant. Results were expressed as mean 6 standard deviation (SD) 
except for the quality of recovery, which was expressed as median 
and interquartile range.
Re s u l t s
The urethral obstruction model demonstrated an increase in 
BUN concentration and creatinine levels, metabolic acidosis, and 
hyperkalemia after a mean period of 42.7 6 2.8 h in the P group and 
39.9 6 1.3 h in the KD group. All animals presented significant hema-
turia and proteinuria at the moment of relief of urethral obstruction. 
An additional dose of propofol (2.5 mg/kg BW, IV) was required 
in all animals in the P group at the moment of bladder lavage. The 
time to standing was 16 min (10/20) in P and 75 min (45/90) in KD 
(P = 0.004). No differences were observed in the quality of recovery 
between the 2 groups, with the KD group scoring 4 (3/5) and the 
P group scoring 5 (1/5).
In the KD group, there was a significant drop in Hct from 2 h to 
7 d (P , 0.001), whereas in P, Hct dropped from 0 h to 7 d (P , 0.001) 
(Table I), with values below the reference range (2) observed after 
8 h in both groups. Total plasma protein (TPP) remained decreased 
at almost all intervals in both groups and, although there were some 
differences between each group, the concentration profile remained 
very similar (Table I). In relation to albumin, the groups differed 
from each other at basal time (P , 0.001) and at 48 h (P = 0.007), 
at which time there were higher values in the KD group (Table I). 
Total protein (TP) values were significantly decreased compared to 
baseline from 2 to 12 h and at 48 h in the P group (P = 0.017) (Table I).
Blood urea nitrogen (BUN) concentration increased significantly 
compared to baseline from the 0 to 8 h time point in both groups 
(P , 0.001) and was above reference values (2) for up to 12 h (Table I). 
Serum creatinine concentration values increased significantly in rela-
tion to reference values (2) for up to 8 h in both groups (Table I). In the 
KD group, serum creatinine increased significantly compared to base-
line at 0 and 2 h (P , 0.001), while in the P group, serum creatinine 
increased at 0, 2, and 8 h (P , 0.001). Moreover, P had significantly 
higher values at 2 h of evaluation than the KD group (P = 0.036). No 
differences were observed between groups in relation to UO, which 
decreased significantly in both groups at 48 h in relation to previous 
intervals (P , 0.001) (Table I). 
The blood gas analysis showed that acidosis (2) was observed for 
up to 2 h in both groups and pH and bicarbonate (HCO3
2) concentra-
tions were significantly lower than at baseline (P , 0.001) (Table II). 
The sodium concentration remained low in the KD group only before 
relief (0 h) (P = 0.039) and it remained low for up to 2 h (P = 0.017) in 
the P group. The potassium concentration increased significantly from 
baseline values at 0 and 2 h in both groups (P , 0.001). There were 
no statistical variations in chloride compared to baseline, although 
chloride increased in relation to reference values at 2 h and at 24 h 
in the KD group. Base excess was significantly decreased compared 
to baseline at 0 h and 2 h in the P group and at 0, 2, and 24 h in the 
KD group (P , 0.001). There were no statistical variations in either 
anion gap or partial pressure of carbon dioxide in mixed venous 
blood (pvCO2) during the evaluated period and observed values were 
also within or very close to the reference interval for the species (2).
D i s c u s s i o n
Both anesthetic protocols used provided adequate conditions for 
manipulation during the urethral relief procedure. At the moment 
of bladder lavage, however, animals in the P group required an 
additional dose of propofol, probably due to the drug’s short period 
of action. Propofol promotes arterial hypotension in cats as well as 
respiratory depression and possibly alters heart rate (13). Apnea is 
also frequently observed after anesthetic induction with propofol 
(18,19). Although these complications were not observed in this 
study (data not shown), they can be harmful in animals with severe 
systemic alterations and can also prolong the hydroelectrolytic sta-
bilization of these animals.
There was no difference in the quality of recovery between the 
2 groups. Time to standing was the evaluated parameter that varied 
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the most between the groups. It is known that propofol prolongs 
anesthetic recovery in cats only when administered by infusion for 
more than 120 min (16) or when administered on consecutive days 
(20). Cats metabolize phenolic compounds slowly, however, as 
these compounds undergo glucuronidation and cats are deficient 
in hepatic glucuronyl transferase (21). Ketamine is often combined 
with benzodiazepines for induction and short-term anesthesia in 
cats (14,22,23), but there have been reports of undesirable behavioral 
effects, such as excitation, agitation, and vocalization (24). These 
effects were not observed in the present study, however, which 
makes the combination of ketamine and diazepam a safe option that 
is easily administered for clinical management of urethral obstruc-
tion in cats. Cats anesthetized with propofol, however, showed a 
shorter time to standing than cats in the KD group, which can be 
explained by propofol’s shorter period of action.
Metabolic acidosis and hyperkalemia were observed in both 
groups for up to 2 h after urethral relief and were treated by infus-
ing lactated Ringer’s solution at adequate rates. Acidemia has long 
been recognized as the primary acid-base disturbance associated 
with urethral obstruction in cats and is a marker for the severity of 
disease (4). Intense metabolic acidosis (pH , 7.2) causes changes 
in the respiratory, cardiovascular, and central nervous systems (1). 
Hyperkalemia is considered to be the most common life-threatening 
complication in this condition (25), as it reduces the resting potential 
of cell membranes of the myocardium, which produces a depolariz-
ing blockade effect and decreases electric conduction (26). As a result, 
muscle weakness and alteration of electric impulse propagation of 
cardiac cells occur (26).
Both pH and base excess decreased in the 2 groups because of an 
accumulation of hydrogen (H1), lactate, and other metabolic acid 
waste caused by a marked decrease in the glomerular filtration rate 
(27). Cats in both groups had hyperchloremic metabolic acidosis at 
0 and 2 h since there was no change in the anion gap. There was an 
increase in the serum chloride to balance the low HCO3
2 concentra-
tion (28). After relief of urethral obstruction, glomerular filtration 
returns and acid excretion became normal, normalizing blood pH. 
As lactated Ringer’s solution has bicarbonate precursors, it was 
observed that this parameter had already stabilized at 8 h.
With the use of intensive fluid therapy, it has been reported that 
blood urea nitrogen (BUN) concentrations stabilize only 48 h after 
urethral relief (29), although in this study the BUN concentration 
stabilized at 24 h in both groups. It was observed, however, that 
creatinine stabilized faster (8 h) in cats in the KD group than in those 
in the P group (12 h). During induction of anesthesia with propofol, 
the decrease in arterial pressure in association with decreases in 
cardiac output and systemic vascular resistance (15) can worsen 
renal perfusion in cats with urethral obstruction and might prolong 
creatinine stabilization. Blood urea nitrogen (BUN), creatinine, 
phosphorus, and other osmotically active solutes accumulate due 
to impaired renal function. This post-renal azotemia is due to 
backpressure induced by the obstruction to outflow, which impairs 
glomerular filtration, tubular function, and renal blood flow (2). The 
prolonged elevation of BUN concentration reflects the decrease in 
glomerular filtration rate and tubular dysfunction during the post-
obstructive period (4,30). In addition, sodium excretion, which is 
a good indicator of renal blood flow (31), remained within physi-
ological values (2) after the obstructed urethra was relieved in both 
groups.
To clinically stabilize the animals, fluid therapy with lactated 
Ringer’s solution 15 min before urethral relief was chosen (32), as 
well as gradually reducing its infusion rate (1,32). Lactated Ringer’s 
solution has been shown to be more efficient than 0.9% sodium 
chloride (NaCl) in stabilizing acid-base and electrolytes in cats 
with urethral obstruction (17). In addition, there is no evidence that 
lactated Ringer’s solution increases potassium serum or impairs 
its stabilization in cats (17,33). Most patients treated with lactate-
containing replacement solutions respond well to the acidosis treat-
ment, probably as a result of expansion of extracellular fluid volume 
and improved tissue perfusion (34). The incidence of cardiotoxicity 
in cats with severe urethral obstruction, due to acidosis and hyper-
kalemia, causes venoconstriction and negative cardiac inotropism, 
which can lead to fluid overload when small quantities of fluids are 
administered (35).
In both groups, urinary output (UO) was significantly increased at 
all time points evaluated, compared with the reference values for cats 
(1 to 2 mL/kg BW per h). This was a result of the increase in renal 
intratubular hydrostatic pressure (35) and post-obstructive diuresis, 
which is a mechanism for maintaining the electrolytic balance and 
increasing the excretion of metabolites retained  during urethral 
obstruction (27). It is important to administer fluids and electro-
lytes to maintain renal function and hydration of the patient (8). 
Measuring UO is fundamental for monitoring dehydration, which 
can occur due to post-obstructive diuresis (32,35). Moreover, adjust-
ment of fluid therapy and maintenance of urinary output are funda-
mental for adequate excretion of anesthetics.
The hallmark of post-obstructive diuresis is increased urine 
production, which can be caused by a combination of physiological 
factors (36). After urinary obstruction is resolved, glomerular filtra-
tion rate and renal blood flow are reduced (36,37). As a result, in the 
post-obstruction period, diuresis is secondary to impaired tubular 
reabsorption of glomerular filtrate (36), which can be caused by BUN 
osmotic diuresis, expansion of extracellular fluid volume, altered 
intrarenal physical factors secondary to elevated intrarenal pressure, 
vasopressin insensitivity, and alterations in other natriuretic factors 
yet to be defined (36–39).
In both groups, Hct decreased significantly at almost all time 
points. This was probably caused by hematuria as a result of 
vessels rupturing subsequent to vesical hyperdistension (35), as 
well as hemodilution caused by fluid therapy and the cumula-
tive volume of blood collected for assessment. Although TP and 
TPP remained within physiological parameters (2), the reductions 
observed in both groups in relation to baseline may have been due 
to proteinuria, proteic catabolism (30,40), hemodilution, and blood 
collections.
As cats with urethral obstruction have different acid-base and 
biochemical disturbances, fluid therapy should be started as soon 
as possible, that is before anesthesia, to relieve the urethral obstruc-
tion. Some cats, however, did not allow the venipuncture required 
to initialize the fluid therapy even with severe clinical and meta-
bolic disturbances. In these cases, the combination of ketamine and 
diazepam is quite advantageous because it can be administered 
intramuscularly.
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Based on the results obtained in this study, both propofol and 
the ketamine-diazepam combination allowed adequate manipula-
tion to initiate the procedure to relieve urethral obstruction. The 
acid-base and biochemical stabilization were very similar in both 
groups. While cats that received propofol recovered much faster, 
the ketamine-diazepam combination was better for use with unco-
operative cats as it can be administered through IM injection, which 
facilitates animal restraint as venipuncture is not required.
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